Normal view MARC view ISBD view

Evaluation of methyl methacrylate monomer cytotoxicity in dental lab technicians using buccal micronucleus cytome assay. [electronic resource]

By:

Azhar, Dawasaz Ali

Contributor(s):

Producer: 20140519Description: 519-21 p. digitalISSN:

1881-1361

Subject(s):

Online resources:

Available from publisher's website

In: Dental materials journal vol. 32

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1 [Treatment of essential thrombocythemia with anagrelide: a ten-year experience].
by Kornblihtt, Laura I
2 Insertion (4;11)(q27;q24q21) in a patient with essential thrombocythemia with progression to myelofibrosis.
by Gargallo, Patricia
3 Synergism of arsenic trioxide and MG132 in Raji cells attained by targeting BNIP3, autophagy, and mitochondria with low doses of valproic acid and vincristine.
by Cavaliere, Victoria
4 Synergism between arsenite and proteasome inhibitor MG132 over cell death in myeloid leukaemic cells U937 and the induction of low levels of intracellular superoxide anion.
by Lombardo, Tomás
5 Moyamoya syndrome in an adolescent with essential thrombocythemia: successful intracranial carotid stent placement.
by Kornblihtt, Laura I
6 [Preferences and limitations of hematologists to address the complexity of myelodysplastic syndromes].
by Crisp, Renée
7 Increased levels of plasma interleukin-6 soluble receptor in patients with essential thrombocythemia.
by Marta, Rosana
8 Regulated Cell Death of Lymphoma Cells after Graded Mitochondrial Damage is Differentially Affected by Drugs Targeting Cell Stress Responses.
by Lombardo, Tomás
9 PDGF-A, PDGF-B, TGFbeta, and bFGF mRNA levels in patients with essential thrombocythemia treated with anagrelide.
by Lev, Paola R
10 A drug potency signature links progression of chronic lymphocytic leukemia to mitochondria-related stress responses and metabolic reprogramming under hypoxia.
by Kornblihtt, Laura I
11 Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation.
by Heller, Paula G
12 JAK2V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status.
by Heller, Paula G